Enhancing dendritic cell vaccination by immune checkpoint blockade as therapy in AML
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
München, Ludwig-Maximilians-Universität, Dissertation, 2020
- Schlagwort
-
Vaccination
Therapeutics
Blockade
- Ereignis
-
Veröffentlichung
- (wo)
-
München
- (wer)
-
Universitätsbibliothek der Ludwig-Maximilians-Universität
- (wann)
-
2020
- Urheber
- Beteiligte Personen und Organisationen
-
Subklewe, Marion
- URN
-
urn:nbn:de:bvb:19-260541
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:43 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rothe, Maurine Daniela Clara
- Subklewe, Marion
- Universitätsbibliothek der Ludwig-Maximilians-Universität
Entstanden
- 2020
Ähnliche Objekte (12)
Current status of dendritic cell-based tumor vaccination
Acute myeloid leukemia (AML) immunotherapy with genetically programmed dendritic cells
Dendritic cell dysfunctions in AML patients with FLT3 ITD mutations
Dendritic Cell dysfunctions in AML patients with FLT3 ITD mutations
Mechanism of dendritic cell-based vaccination against Leishmania major
Improved dendritic cell vaccination for combined melanoma immune therapy
Improved dendritic cell vaccination for combined melanoma immune therapy
Transcriptomics of myeloid dendritic cells during mycobacterial infection and vaccination
Dendritic cell vaccination in pediatric gliomas: lessons learnt and future perspectives
Therapeutic Cancer Vaccination with Ex Vivo RNA-Transfected Dendritic Cells—An Update
"AML!
AML
Current status of dendritic cell-based tumor vaccination
Acute myeloid leukemia (AML) immunotherapy with genetically programmed dendritic cells
Dendritic cell dysfunctions in AML patients with FLT3 ITD mutations
Dendritic Cell dysfunctions in AML patients with FLT3 ITD mutations
Mechanism of dendritic cell-based vaccination against Leishmania major
Improved dendritic cell vaccination for combined melanoma immune therapy
Improved dendritic cell vaccination for combined melanoma immune therapy
Transcriptomics of myeloid dendritic cells during mycobacterial infection and vaccination
Dendritic cell vaccination in pediatric gliomas: lessons learnt and future perspectives
Therapeutic Cancer Vaccination with Ex Vivo RNA-Transfected Dendritic Cells—An Update
"AML!
AML
Current status of dendritic cell-based tumor vaccination
Acute myeloid leukemia (AML) immunotherapy with genetically programmed dendritic cells
Dendritic cell dysfunctions in AML patients with FLT3 ITD mutations
Dendritic Cell dysfunctions in AML patients with FLT3 ITD mutations
Mechanism of dendritic cell-based vaccination against Leishmania major
Improved dendritic cell vaccination for combined melanoma immune therapy
Improved dendritic cell vaccination for combined melanoma immune therapy
Transcriptomics of myeloid dendritic cells during mycobacterial infection and vaccination
Dendritic cell vaccination in pediatric gliomas: lessons learnt and future perspectives
Therapeutic Cancer Vaccination with Ex Vivo RNA-Transfected Dendritic Cells—An Update
"AML!